首页> 美国卫生研究院文献>Aging (Albany NY) >miR-183-5p alleviates early injury after intracerebral hemorrhage by inhibiting heme oxygenase-1 expression
【2h】

miR-183-5p alleviates early injury after intracerebral hemorrhage by inhibiting heme oxygenase-1 expression

机译:MiR-183-5P通过抑制血红素氧合酶-1表达减轻脑出血后早期损伤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Differences in microRNA (miRNA) expression after intracerebral hemorrhage (ICH) have been reported in human and animal models, and miRNAs are being investigated as a new treatment for inflammation and oxidative stress after ICH. In this study, we found that microRNA-183-5p expression was decreased in the mouse brain after ICH. To investigate the effect of miRNA-183-5p on injury and repair of brain tissue after ICH, saline, miRNA-183-5p agomir, or miRNA-183-5p antagomir were injected into the lateral ventricles of 8-week-old mice with collagenase-induced ICH. Three days after ICH, mice treated with exogenous miRNA-183-5p showed less brain edema, neurobehavioral defects, inflammation, oxidative stress, and ferrous deposition than control mice. In addition, by alternately treating mice with a heme oxygenase-1 (HO-1) inducer, a HO-1 inhibitor, a nuclear factor erythroid 2-related factor (Nrf2) activator, and Nrf2 knockout, we demonstrated an indirect, HO-1-dependent regulatory relationship between miRNA-183-5p and Nrf2. Our results indicate that miRNA-183-5p and HO-1 are promising therapeutic targets for controlling inflammation and oxidative damage after hemorrhagic stroke.
机译:在人和动物模型中报道了在人和动物模型中报道了脑内出血(ICH)后MicroRNA(miRNA)表达的差异,并且在ICH后的炎症和氧化应激的新治疗中被研究。在这项研究中,我们发现在ICH之后小鼠脑中的MicroRNA-183-5P表达减少。探讨miRNA-183-5P对ICH,盐水,miRNA-183-5P AGOMIR或MiRNA-183-5P Antagomir的伤害和修复脑组织的损伤和修复的影响被注入8周龄小鼠的侧脑室胶原酶诱导的ICH。在ICH后三天,用外源miRNA-183-5P处理的小鼠显示出较少的脑水肿,神经衰有缺损,炎症,氧化应激和黑色沉积而不是对照小鼠。另外,通过交替用血红素氧酶-1(HO-1)诱导剂的小鼠,HO-1抑制剂,核因子红外2相关因子(NRF2)活化剂和NRF2敲除,我们展示了一个间接,何地miRNA-183-5P和NRF2之间的1依赖性调节关系。我们的结果表明,MiRNA-183-5P和HO-1是有前途的治疗靶标,用于控制出血性卒中后的炎症和氧化损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号